Skip to main content
. 2018 Nov 19;21(4):547–557. doi: 10.1093/neuonc/noy191

Fig. 2.

Fig. 2

Outcomes for re-irradiated patients with local failure, by RT2 field and site of disease. (A) Freedom from progression in patients with infratentorial (IT) primaries. (B) Overall survival in patients with IT primaries. (C) Freedom from progression in patients with supratentorial (ST) primaries. (D) Overall survival in patients with ST primaries. (E) Freedom from progression in all patients. (F) Overall survival in all patients.